Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | PPARA | Q07869 | 1/20 | 0.58 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | MMP1 | P03956 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30539404 | 0.95 | PPARA (0.65) | L3MBTL1PPARAPDE4BNPC1MAPT | |
| SCHEMBL20278587 | 0.86 | GAA (0.67) | L3MBTL1NPC1MAPTSMN1; SMN2RAB9A | |
| SCHEMBL10040898 | 0.86 | L3MBTL1 (0.69) | L3MBTL1NPC1MAPTMMP1SMN1; SMN2 | |
| SCHEMBL17129733 | 0.86 | L3MBTL1 (0.62) | L3MBTL1NPC1MAPTMMP1SMN1; SMN2 | |
| SCHEMBL9077658 | 0.85 | L3MBTL1 (0.73) | L3MBTL1PPARAPDE4BNPC1MMP1 | |
| SCHEMBL29089242 | 0.84 | PLA2G4B (0.68) | L3MBTL1PPARATP53TSHRGAA | |
| SCHEMBL31448501 | 0.84 | PPARA (0.65) | L3MBTL1PPARAGAAPLA2G4B | |
| SCHEMBL3446913 | 0.83 | L3MBTL1 (0.71) | L3MBTL1NPC1MAPTMMP1SMN1; SMN2 | |
| SCHEMBL6640853 | 0.83 | L3MBTL1 (0.60) | L3MBTL1NPC1MAPTMMP1SMN1; SMN2 | |
| SCHEMBL445511 | 0.83 | L3MBTL1 (0.76) | L3MBTL1PPARAMAPTSMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116693416-B | Aryloxy aminobenzoic acid derivative, and preparation method and application thereof | 桂林医学院 | 2025-01-07 | — | — | CN | disclosed |
| CN-116693416-A | Aryloxy aminobenzoic acid derivative, and preparation method and application thereof | 桂林医学院 | 2023-09-05 | — | — | CN | disclosed |
| EP-1389616-B1 | 3,4-Dihalobenzylpiperidine derivatives and their medical use | MITSUBISHI TANABE PHARMA CORP (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-7115635-B2 | Benzylpiperidine compound | MITSUBISHI PHARMA CORPORATION (JP) | 2006-10-03 | — | — | US | disclosed |
| US-20040158071-A1 | Chemokine inhibitors and stability in blood | MITSUBISHI PHARMA CORPORATION (JP) | 2004-08-12 | — | — | US | disclosed |
| EP-1389616-A1 | NOVEL BENZYLPIPERIDINE COMPOUND | Mitsubishi Pharma Corporation (JP) | 2004-02-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040158071-A1 | Chemokine inhibitors and stability in blood | CCL2, CXCR1, CCR5 | L3MBTL1 3984/4885PPARA 1804/4885PDE4B 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.